Found: 7
Select item for more details and to access through your institution.
CK2 Molecular Targeting-Tumor Cell-Specific Delivery of RNAi in Various Models of Cancer.
- Published in:
- Pharmaceuticals (14248247), 2017, v. 10, n. 1, p. 25, doi. 10.3390/ph10010025
- By:
- Publication type:
- Article
Nanocapsule-delivered Sleeping Beauty mediates therapeutic Factor VIII expression in liver sinusoidal endothelial cells of hemophilia A mice.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Tenfibgen Ligand Nanoencapsulation Delivers Bi-Functional Anti-CK2 RNAi Oligomer to Key Sites for Prostate Cancer Targeting Using Human Xenograft Tumors in Mice.
- Published in:
- PLoS ONE, 2014, v. 9, n. 10, p. 1, doi. 10.1371/journal.pone.0109970
- By:
- Publication type:
- Article
Preclinical evaluation of cyclin dependent kinase 11 and casein kinase 2 survival kinases as RNA interference targets for triple negative breast cancer therapy.
- Published in:
- Breast Cancer Research, 2015, v. 17, n. 1, p. 1, doi. 10.1186/s13058-015-0524-0
- By:
- Publication type:
- Article
Preclinical evaluation of cyclin dependent kinase 11 and casein kinase 2 survival kinases as RNA interference targets for triple negative breast cancer therapy.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Quantitative assessment of leading edge adhesion: Reattachment kinetics modulated by injury-derived intracellular calcium predict wound closure rates in endothelial monolayers.
- Published in:
- Journal of Cellular Physiology, 1998, v. 174, n. 2, p. 217, doi. 10.1002/(SICI)1097-4652(199802)174:2<217::AID-JCP9>3.0.CO;2-R
- By:
- Publication type:
- Article
1081. Targeted Nanocapsules for Liver Cell-Type Delivery of Plasmids In Vivo.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S415, doi. 10.1016/j.ymthe.2006.08.1182
- By:
- Publication type:
- Article